Alcohol use disorder treatment for executives

Professionals and executives undergoing treatment for alcohol use disorder are increasingly utilizing medication-assisted treatment and recovery skills to support long-term sobriety and leadership capabilities.

Vivitrol, an extended-release monthly injection of naltrexone, is used in residential programs to reduce the reward pull of alcohol by blocking opioid receptors. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) recognizes naltrexone as one of three FDA-approved medications for alcohol use disorder. The monthly injection format is noted for its benefit in high-travel professional populations, as it removes the need for daily oral adherence during high-risk periods.

Beyond clinical intervention, the recovery process is framed as an opportunity to develop leadership qualities. Skills such as self-awareness, accountability, emotional regulation, and honest communication are identified as core components of recovery that translate directly to effective professional management and workplace credibility.